All Blogs / Industries / Medical / Pharmaceutical / Popular


How Payers Contributed to the EpiPen Pricing Controversy

Ronny Gal, Ph.D., a senior analyst at the investment bank Sanford C. Bernstein & Co., just published a great client note on the Mylan EpiPen pricing brouhaha. Ronny graciously agreed to let me share his viewpoints below. As a contrast to the mainstream media coverage, Ronny offers a grounded, industry-informed perspective. Show More Summary

Drug Channels News Roundup, August 2016: Rite Aid, Teva, Anda, AmerisourceBergen, Specialty Pharmacies, and Walmart

Sigh. Summer is almost over. Time to pack away your bathing suit, send the kids back to school, and savor this curated collection of curiosities, combed from the Drug Channels beach. In this issue: Mini me! Rite Aid finally launchesShow More Summary

This is Your State, This is Your State on Drugs

I always enjoy doing a periodic check in on what states are doing when it comes to healthcare issues. Utilizing the excellent data base resources at the National Conference of State Legislatures, one can examine numerous categories of legislation that … Continue reading ?

7th Specialty Product Distribution and Channel Optimization Summit

7th Specialty Product Distribution and Channel Optimization SummitOctober 26-27, 2016 | Princeton, NJThis October, navigate evolving trends, models and strategies to propel commercial success and ensure patient access at the 7th Specialty Product Distribution and Channel Optimization Summit. Show More Summary

The Addyi Report Card: Crooked Valeant Fools FDA Again

Click on image for enlarged view or get PDF here. "Fool me once, shame on you; fool me twice, shame on me," should be FDA's response to a report card released by the National Women’s Health Network advocacy group and shown here. FDAShow More Summary

Retail Pharmacist Salary Growth Stalls, while Hospital Pharmacists’ Salaries Rise

There’s some bad news in our latest exclusive annual analysis of pharmacist salaries, based on the Bureau of Labor Statistics’ (BLS) recently released Occupational Employment Statistics (OES). In 2015, the average gross base salary for a pharmacist at a retail, mail, and specialty pharmacy was $119,517—up a paltry 0.1% from 2014. Show More Summary

Highlighting notable helminth research and a PLOS Science Weds AMA preview for #WormWeek

Update 8/17/16: read the PLOS Science Weds discussion on this topic To many people, worms are considered harmless creatures, if not a little yucky. But don’t be fooled by their small and innocuous size, some worms

AdComm Recommendations – How Often FDA Does Not Follow Them?

When an FDA Advisory Committee meets and deliberates whether or not the new drug application put before the agency should or should not be approved, they gather together and deliberate in a public forum often for hours. Prior to the … Continue reading ?

Catching Up with Valeant and Walgreens—and Their New Best Friend

Attention, trainers! Time for an update on Valeant and its relationship with Walgreens Boots Alliance (WBA), the biggest and most difficult to catch Pokémon. Last week, Valeant revealed that in the first six months of 2016, its sales via Walgreens were about $150 million. Show More Summary

Highlighting notable helminth research and a PLOS Science Weds AMA preview for #WormWeek

To many people, worms are considered harmless creatures, if not a little yucky. But don’t be fooled by their small and innocuous size, some worms are parasitic, and are the cause of substantial disability for

Now May Be the Time for Pharma to Get Serious About Instagram

Despite the fact that FDA recently cited Duchesnay for a violative Instagram Diclegis ad that featured celebutante Kim Kardashian (read "Kim Kardashian Instagram post draws FDA warning"), Instagram may be the social medium of choice of pharma marketers now that it has added a new feature. Until now, I didn't think Instagram was good for pharma. Show More Summary

AMP Final Rule: Your First Chance to Discuss the Application, Implementation, and Impact at MDRP

Medicaid Drug Rebate Program Summit 2016 is a platform to connect with 550+ MDRP executives and 100+ industry experts and deep dive into the most critical elements of the rule and provide you with instruction on how to manage them. Roll up your sleeves and work with colleagues to best embrace the adjustments you need to make. Show More Summary

Do Desperate Consumers Believe Cancer Drug DTC Ads?

In a recent NYT OpEd piece, Matt Jablow, whose wife died of lung cancer, called the TV ads for BMS's cancer drug Opdivo "utterly misleading and exploitive" and said that if BMS really wishes to thank patients like his wife who participated...Show More Summary

Bringing Calm to the World of Complex Specialty Therapies

Today’s guest blog post comes from Nicole Hebbert, Vice President of Patient Access and Engagement at United BioSource Corp. (UBC). Nicole discusses next generation patient support centers, a.k.a., hubs, that leverage technology to address patients' challenges between diagnosis and access to therapy. Show More Summary

Copyright © 2015 Regator, LLC